Table 3 Post screening/treatment follow-up
From: Cervical cancer prevention in countries with the highest HIV prevalence: a review of policies
Recommended rescreening interval | ||||
|---|---|---|---|---|
Country | Screen negative | After treatment | ||
HIV negative | HIV positive | HIV negative | HIV positive | |
Botswana | NR | NR | NR | NR |
Eswatini | NR | NR | NR | NR |
Lesotho | 3–5 years | 2 years | 1 year post treatment then return to routine screening | 6 months post treatment then yearly screening thereafter |
Malawi | 3 years | 2 years | Yearly for 3 years then return to routine screening | |
Mozambique | NR | NR | NR | NR |
Namibia | 5 years | 3 years | Yearly for 3 consecutive years then return to routine screening | Yearly for 3 consecutive years then return to routine screening |
South Africa | 10 years | 3 years | Yearly | Yearly until lesion-free then return to routine screening |
Zambia | 5 years | 3 years | NR | Yearly |
Zimbabwe | 3 years | yearly | 1 year post treatment | 1 year post treatment |